Literature DB >> 16794238

Cancer in 15- to 29-year-olds by primary site.

Archie Bleyer1, Aaron Viny, Ronald Barr.   

Abstract

INCIDENCE: Cancer occurring between the ages of 15 and 30 years is 2.7 times more common than cancer occurring during the first 15 years of life, yet is much less common than cancer in older age groups, and accounts for just 2% of all invasive cancer. Cancer in adolescents and young adults is unique in the distribution of the types that occur. Hodgkin lymphoma, melanoma, testis cancer, female genital tract malignancies, thyroid cancer, soft-tissue sarcomas, non-Hodgkin lymphoma, leukemia, brain and spinal cord tumors, breast cancer, bone sarcomas, and nongonadal germ cell tumors account for 95% of the cancers in this age group. The frequency distribution of cancer types changes dramatically from age 15-30, such that the pattern at the youngest age does not resemble the one at the oldest. The incidence of cancer in this age group increased steadily during the past quarter century. This increase is declining and at the older end of the age range appears to be returning to the incidence of the 1970s. Males in the 15- to 29-year age group have been at higher risk of developing cancer, with the risk directly proportional to age. Non-Hispanic whites have had the highest risk of developing cancer during this phase of life, and Asians, American Indians and Native Alaskans the lowest. Males had a worse prognosis than females. African-Americans, American Indian/Alaska Natives had a worse prognosis than white non-Hispanics and Asians. MORTALITY & SURVIVAL: At the beginning of the last quarter century, the diagnosis of cancer in 15- to 29-year-olds carried a more favorable prognosis, on the average, relative to cancer at other ages. Since then, there has been a lack of progress in survival improvement among older adolescents and young adults relative to all other ages. Survival improvement trends portend a worse prognosis for young adults diagnosed with cancer today than 25 years ago. The survival deficit is increasing with longer follow-up of the survivors, and is worse in males. Among 15- to 29-year-olds, non-Hispanic whites had the best survival and African Americans/blacks had the worst survival, with a 20% difference apparent by 5 years. Asians/Pacific Islanders had the second best survival, with Hispanics and American Indians/Alaska Natives next in sequence. RISK FACTORS: In general, there are relatively scant data to support either an environmental causation or an inherited predisposition to cancer in this age group. The majority of cases of cancer occurring before age 30 appear to be spontaneous and unrelated to either carcinogens in the environment or family cancer syndromes. Overall, family cancer syndromes appear to account for less than 5% of the cases of cancer in the age group. Melanoma, cervical carcinoma and Kaposi sarcoma, non-Hodgkin lymphoma, Hodgkin and Burkitt lymphomas accounting for the majority of environmentally induced malignancies (ultraviolet light, human papillomavirus, human immunodeficiency virus, and Epstein-Barr virus, respectively). Ultimately, a larger proportion of cases may be attributable to specific factors or genetic predisposition, but at present, most cancer in this age group appears to be sporadic and random.

Entities:  

Mesh:

Year:  2006        PMID: 16794238     DOI: 10.1634/theoncologist.11-6-590

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  74 in total

1.  "You're too young for this": adolescent and young adults' perspectives on cancer survivorship.

Authors:  Erin E Kent; Carla Parry; Michael J Montoya; Leonard S Sender; Rebecca A Morris; Hoda Anton-Culver
Journal:  J Psychosoc Oncol       Date:  2012

2.  Health status of adolescent and young adult cancer survivors.

Authors:  Eric Tai; Natasha Buchanan; Julie Townsend; Temeika Fairley; Angela Moore; Lisa C Richardson
Journal:  Cancer       Date:  2012-06-11       Impact factor: 6.860

Review 3.  Canadian adolescents and young adults with cancer: opportunity to improve coordination and level of care.

Authors:  Prithwish De; Larry F Ellison; Ronald D Barr; Robert Semenciw; Loraine D Marrett; Hannah K Weir; Dagny Dryer; Eva Grunfeld
Journal:  CMAJ       Date:  2011-02-22       Impact factor: 8.262

4.  Thirty-Five Years of Thyroid Cancer Experience in a Paediatric Population: Incidence Trends in Lithuania between 1980 and 2014.

Authors:  Rima Bėrontienė; Edita Jašinskienė; Rosita Kiudelienė; Gintaras Kuprionis; Jurgita Makštienė; Raminta Macaitytė; Dalia Marčiulionytė; Lina Poškienė; Agnė Šemetaitė; Vygantas Šidlauskas; Raimondas Valickas; Rimantas Žalinkevičius; Rasa Verkauskienė
Journal:  Eur Thyroid J       Date:  2016-11-09

5.  Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children.

Authors:  Yelena P Wu; Bridget G Parsons; Ryan Mooney; Lisa G Aspinwall; Kristin Cloyes; Jennifer L Hay; Wendy Kohlmann; Douglas Grossman; Sancy A Leachman
Journal:  J Community Health       Date:  2018-10

6.  Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006.

Authors:  Hannah K Weir; Loraine D Marrett; Vilma Cokkinides; Jill Barnholtz-Sloan; Pragna Patel; Eric Tai; Ahmedin Jemal; Jun Li; Julian Kim; Donatus U Ekwueme
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

Review 7.  Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Authors:  Ronald N Hines; Dana Sargent; Herman Autrup; Linda S Birnbaum; Robert L Brent; Nancy G Doerrer; Elaine A Cohen Hubal; Daland R Juberg; Christian Laurent; Robert Luebke; Klaus Olejniczak; Christopher J Portier; William Slikker
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

8.  Microrandomized trials for promoting engagement in mobile health data collection: Adolescent/young adult oral chemotherapy adherence as an example.

Authors:  Shuang Li; Alexandra M Psihogios; Elise R McKelvey; Annisa Ahmed; Mashfiqui Rabbi; Susan Murphy
Journal:  Curr Opin Syst Biol       Date:  2020-07-07

9.  Epidemiology and cost analysis for patients with oral cancer in a university hospital in China.

Authors:  Sheng Han; Yan Chen; Xu Ge; Ming Zhang; Jinwei Wang; Qingbo Zhao; Jianjun He; Zhenghong Wang
Journal:  BMC Public Health       Date:  2010-04-16       Impact factor: 3.295

Review 10.  Pregnancy and breast cancer: when they collide.

Authors:  Traci R Lyons; Pepper J Schedin; Virginia F Borges
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-21       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.